Cargando…
Prior antiplatelet therapy in patients undergoing endovascular treatment for acute ischemic stroke: Results from the MR CLEAN Registry
BACKGROUND: Antiplatelet therapy may increase the risk of symptomatic intracranial hemorrhage after endovascular treatment for ischemic stroke but may also have a beneficial effect on functional outcome. The aim of this study is to compare safety and efficacy outcomes after endovascular treatment in...
Autores principales: | van de Graaf, Rob A, Zinkstok, Sanne M, Chalos, Vicky, Goldhoorn, Robert-Jan B, Majoie, Charles BLM, van Oostenbrugge, Robert J, van der Lugt, Aad, Dippel, Diederik WJ, Roos, Yvo BWEM, Lingsma, Hester F, van Es, Adriaan CGM, Roozenbeek, Bob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193619/ https://www.ncbi.nlm.nih.gov/pubmed/32791940 http://dx.doi.org/10.1177/1747493020946975 |
Ejemplares similares
-
Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort Study
por: van der Steen, Wouter, et al.
Publicado: (2022) -
Brain atrophy and endovascular treatment effect in acute ischemic stroke: a secondary analysis of the MR CLEAN trial
por: Luijten, Sven PR, et al.
Publicado: (2021) -
Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design
por: Chalos, Vicky, et al.
Publicado: (2020) -
Timing of symptomatic intracranial hemorrhage after endovascular
stroke treatment
por: van der Steen, Wouter, et al.
Publicado: (2022) -
Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials: A Simulation Study
por: Dijkland, Simone A., et al.
Publicado: (2018)